Latest Regulatory News

PYC Therapeutics has reported encouraging pre-clinical results for its RNA therapy candidate PYC-002 targeting Phelan-McDermid Syndrome, supporting plans to enter human trials in 2026. The data demonstrate safety, brain distribution, and gene expression restoration in key disease regions.

ENRG Elements Ltd’s EELO securities have been suspended from trading by the ASX due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.

Immuron Limited reports a robust 34% year-on-year sales increase for Q1 FY26, driven by strong growth in Australia and the USA, while Canadian sales dip seasonally. The company’s marketing efforts and expanding retail presence underpin this momentum.

Elementos Limited has executed a binding option agreement to acquire half of Iberian Smelting SL, owner of the Robledollano Tin Smelter in Spain, setting the stage for the EU's first vertically integrated primary tin supply chain.

Advance Metals has unveiled an ambitious growth strategy to double its silver-equivalent resource base in Mexico to over 200 million ounces, backed by fresh funding and a suite of exploration initiatives across three high-grade projects.

AdAlta Limited has raised up to A$0.5 million through a premium-priced private placement, bolstering its 'East to West' cellular immunotherapy strategy focused on advancing CAR-T therapies for solid cancers.

3D Energi has raised $9.4 million to fund the drilling of its Essington-1 well in the Otway Basin, with Korea National Oil Corporation acquiring a 29% stake in the joint venture alongside ConocoPhillips. Drilling is set to commence in late October 2025.

PainChek Limited has secured its first US customer, Jewish Home Family, just days after receiving FDA De Novo clearance for its AI-powered pain assessment app, marking a significant step into the $100 million US aged care market.

IsoEnergy Ltd. is set to acquire Toro Energy Ltd., combining two significant uranium portfolios to create a diversified global player with flagship projects in Australia, Canada, and the U.S. This strategic merger positions the new entity to capitalize on rising uranium demand amid a tightening market.

IsoEnergy Ltd. has agreed to acquire Toro Energy Ltd. in a deal that significantly expands its uranium portfolio, adding the Wiluna Uranium Project in Western Australia and creating a diversified, top-tier uranium development platform.

RPMGlobal Holdings Limited has agreed to be acquired by Caterpillar Inc. through a Scheme of Arrangement valuing the company at over $1.1 billion, offering shareholders a 32.6% premium. The deal awaits regulatory and shareholder approvals, marking a significant consolidation in mining software technology.

Immutep Limited has confirmed 30 mg as the optimal biological dose for its immunotherapy efti, following FDA approval of Project Optimus requirements. This milestone paves the way for the US launch of its pivotal Phase III lung cancer trial.